Anti-PSG4/ PSBG-4/ PSBG-9 monoclonal antibody

Anti-PSG4/ PSBG-4/ PSBG-9 antibody for FACS & in-vivo assay

Target products collectionGo to PSG4/PSG4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2565-Ab-1/ GM-Tg-hg-MP2565-Ab-2Anti-Human PSG4 monoclonal antibodyHuman
GM-Tg-rg-MP2565-Ab-1/ GM-Tg-rg-MP2565-Ab-2Anti-Rat PSG4 monoclonal antibodyRat
GM-Tg-mg-MP2565-Ab-1/ GM-Tg-mg-MP2565-Ab-2Anti-Mouse PSG4 monoclonal antibodyMouse
GM-Tg-cynog-MP2565-Ab-1/ GM-Tg-cynog-MP2565-Ab-2Anti-Cynomolgus/ Rhesus macaque PSG4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2565-Ab-1/ GM-Tg-felg-MP2565-Ab-2Anti-Feline PSG4 monoclonal antibodyFeline
GM-Tg-cang-MP2565-Ab-1/ GM-Tg-cang-MP2565-Ab-2Anti-Canine PSG4 monoclonal antibodyCanine
GM-Tg-bovg-MP2565-Ab-1/ GM-Tg-bovg-MP2565-Ab-2Anti-Bovine PSG4 monoclonal antibodyBovine
GM-Tg-equg-MP2565-Ab-1/ GM-Tg-equg-MP2565-Ab-2Anti-Equine PSG4 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2565-Ab-1/ GM-Tg-hg-MP2565-Ab-2; GM-Tg-rg-MP2565-Ab-1/ GM-Tg-rg-MP2565-Ab-2;
GM-Tg-mg-MP2565-Ab-1/ GM-Tg-mg-MP2565-Ab-2; GM-Tg-cynog-MP2565-Ab-1/ GM-Tg-cynog-MP2565-Ab-2;
GM-Tg-felg-MP2565-Ab-1/ GM-Tg-felg-MP2565-Ab-2; GM-Tg-cang-MP2565-Ab-1/ GM-Tg-cang-MP2565-Ab-2;
GM-Tg-bovg-MP2565-Ab-1/ GM-Tg-bovg-MP2565-Ab-2; GM-Tg-equg-MP2565-Ab-1/ GM-Tg-equg-MP2565-Ab-2
Products NameAnti-PSG4 monoclonal antibody
Formatmab
Target NamePSG4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PSG4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PSG4/ PSBG-4/ PSBG-9 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2565
    Target NamePSG4
    Gene ID5672
    Gene Symbol and SynonymsPSBG-4,PSBG-9,PSG4,PSG9
    Uniprot AccessionQ00888
    Uniprot Entry NamePSG4_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000243137
    Target ClassificationN/A

    The target: PSG4, gene name: PSG4, also named as PSBG-4, PSBG-9, PSG9. The protein encoded by this gene is a pregnancy-specific glycoprotein (PSG), one of several encoded by a cluster of similar genes on chromosome 19. This gene is a member of the carcinoembryonic antigen (CEA) gene family and may play a role in regulation of the innate immune system. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.